Roche has bought Inflazome for €380 million ($451 million) upfront to gain control of treatments for inflammatory diseases. The deal gives Roche full rights to a pipeline of oral NLRP3 ...
It’s 2020 and the ideological divide between the Biotech industry and academic research is closing fast.
The first wave of immuno-oncology drugs was targeted at immune checkpoints and produced blockbusters like Merck’s PD-1 inhibitor Keytruda. The next wave includes second-generation ...
Colorifix is a biotechnology company that aims to bring a novel, sustainable and environmentally-friendly process to the textile dyeing industry by eliminating the use of hazardous ...
Debut Bio’s biosynthesis platform provides a scalable biomanufacturing approach while eliminating the need for traditional precious metal catalysts and toxic reagents SAN DIEGO ...
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
After a long career in research, this scientist found an unexpected way to help people
When a researchers talk about gene editing, they're usually thinking about several steps. First you need to zero in on the defective gene; then, depending on the need, you’d want to knock ...